Congress trades
LGND Ligand Pharmaceuticals Incorporated
Members of Congress who traded or hold Ligand Pharmaceuticals Incorporated, from their STOCK Act disclosures. None of the featured 13F managers hold it, so this page covers Congress only. LGND earnings.
- 1 members traded it since Oct 4, 2023
- 4 / 0 buys / sales
- 0 held it at year end
- May 29, 2026 latest trade
Trades
4 trades since Oct 4, 2023 · newest filings first
-
LGNDLigand Pharmaceuticals IncorporatedBuy$1K–$15KTraded May 29Filed Jun 8 10d
-
LGNDLigand Pharmaceuticals IncorporatedBuy$1K–$15KTraded Mar 3Filed Apr 7 35d
-
LGNDLigand Pharmaceuticals IncorporatedBuy$1K–$15KTraded Jan 15Filed Feb 13 29d
-
LGNDLigand Pharmaceuticals IncorporatedBuy$1K–$15KTraded Jan 5Filed Feb 13 39d
No trades match these filters.
Amounts are the ranges members disclose. Trades cover the last three years; holdings come from each member's latest annual report. All Congress trades · How we read these reports.